NCT04388176View on ClinicalTrials.gov

Cold Challenge With C21 in RP

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 3, 2020

Primary Completion Date

December 14, 2020

Study Completion Date

December 14, 2020

Conditions
Raynaud PhenomenonSystemic Sclerosis
Interventions
DRUG

C21

C21 as first treatment

DRUG

C21

C21 as second treatment

DRUG

Placebo

Placebo as second treatment

DRUG

Placebo

Placebo as first treatment

Trial Locations (1)

M6 8HD

Department of Rheumatology, Salford Royal Hospital, Manchester

All Listed Sponsors
collaborator

SGS Life Sciences, a division of SGS Belgium NV

OTHER

lead

Vicore Pharma AB

INDUSTRY

NCT04388176 - Cold Challenge With C21 in RP | Biotech Hunter | Biotech Hunter